Showing results (1121-1130 of 1,404) with videos related to

Sort By:
Pageof 141
Pharmacology Research & Perspectives|October 8, 2024
Histamine H1-receptor-mediated modulation of NMDA receptors signaling responsesJ-M Arrang, V Armand
Pharmacology Research & Perspectives|October 14, 2024
Disposition of orally administered atuliflapon, a novel 5-lipoxygenase-activating protein inhibitor in healthy participantsXue-Qing Li, Bo Lindmark, Carl Amilon, et al.
Pharmacology Research & Perspectives|October 14, 2024
Nutritional strategies for improving sarcopenia outcomes in older adults: A narrative reviewBeatriz R Goes-Santos, Brian P Carson, Guilherme Wesley Peixoto da Fonseca, et al.
Pharmacology Research & Perspectives|October 19, 2024
Therapeutic potential of agents targeting cannabinoid type 2 receptors in organ fibrosisLujain Bader Eddin, M F Nagoor Meeran, Sandeep B Subramanya, et al.
Pharmacology Research & Perspectives|September 25, 2024
The epsilon toxin from Clostridium perfringens stimulates calcium-activated chloride channels, generating extracellular vesicles in Xenopus oocytesMercè Cases, Jonatan Dorca-Arévalo, Marta Blanch, et al.
Pharmacology Research & Perspectives|September 24, 2024
Nicotine addiction and the influence of life adversity and acute stress on PYY: Prediction of early smoking relapseAmanda A Miller, Motohiro Nakajima, Briana N DeAngelis, et al.
Pharmacology Research & Perspectives|October 3, 2024
Effect of mitochondrial coenzyme-Q10 precursor solanesol in gentamicin-induced experimental nephrotoxicity: Evidence from restoration of ETC-complexes and histopathological alterationsMinakshi Sangwan, Hema Chaudhary, Sidharth Mehan, et al.
Pharmacology Research & Perspectives|November 7, 2024
Favipiravir pharmacokinetics in Thai adults with mild COVID-19: A sub-study of interpatient variability and ethnic differences in exposureIng-Orn Prasanchaimontri, Weerawat Manosuthi, Henry Pertinez, et al.
Pharmacology Research & Perspectives|October 29, 2024
Incidence, characteristics, and clinical impact of serious adverse events in patients with breast cancer receiving antineoplastic treatment in the ambulatory settingZahieh AbuAloush, Wedad Awad, Ola Mashni, et al.
Pharmacology Research & Perspectives|October 25, 2024
The preclinical pharmacokinetics of Tolinapant-A dual cIAP1/XIAP antagonist with in vivo efficacyVanessa Martins, George Ward, Tomoko Smyth, et al.
Pageof 141